Jan 05, 2024
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.58 to $0.06.
The split itself did not change the total investment value.
SAB Biotherapeutics, Inc. (SABS) trades on the NASDAQ in the Biotechnology industry.
SAB Biotherapeutics, Inc. company overviewThe latest split shown was on January 5, 2024. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on January 5, 2024.